Integer Holdings Co. (NYSE:ITGR) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP cut its stake in Integer Holdings Co. (NYSE:ITGR) by 30.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,529 shares of the medical equipment provider’s stock after selling 1,559 shares during the period. Bridgewater Associates LP’s holdings in Integer were worth $468,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Raymond James Financial Inc. acquired a new stake in shares of Integer during the fourth quarter worth $38,073,000. Artisan Partners Limited Partnership acquired a new stake in Integer during the 4th quarter worth about $22,775,000. Laurus Investment Counsel Inc. acquired a new stake in Integer during the 4th quarter worth about $5,422,000. New York State Common Retirement Fund grew its stake in Integer by 20.9% during the 4th quarter. New York State Common Retirement Fund now owns 232,569 shares of the medical equipment provider’s stock valued at $30,820,000 after purchasing an additional 40,158 shares during the last quarter. Finally, Wealthfront Advisers LLC acquired a new position in shares of Integer in the fourth quarter valued at about $4,754,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on ITGR shares. Raymond James began coverage on Integer in a research report on Friday, March 28th. They issued an “outperform” rating and a $145.00 target price on the stock. KeyCorp increased their price target on shares of Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Truist Financial cut their price objective on Integer from $163.00 to $140.00 and set a “buy” rating for the company in a research report on Friday, April 11th. Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a report on Friday, February 21st. Finally, Benchmark boosted their target price on shares of Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, February 21st. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $146.00.

Integer Stock Up 0.7 %

Shares of NYSE ITGR opened at $116.99 on Friday. The stock has a market cap of $4.08 billion, a PE ratio of 34.82, a P/E/G ratio of 1.72 and a beta of 1.09. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62. Integer Holdings Co. has a 12-month low of $104.93 and a 12-month high of $146.36. The company has a 50-day moving average of $121.57 and a 200 day moving average of $130.56.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). The company had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. As a group, sell-side analysts predict that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.